Delirium is a sudden onset and temporary state of disturbed consciousness or cognition, occurring due to underlying medical issues like fever or alcohol withdrawal. It is most common among older hospitalized adults aged 75 years or above, leading to increased risk of falls, dementia, low life expectancy, and high health care expenses.
Clinical trial assesses the efficacy of suvorexant in reducing delirium in older adults retrieved 29 August 2024 from https://medicalxpress.com/news/2024-08-clinical-trial-efficacy-suvorexant-delirium.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Comprehensive review highlights urgent need for frailty-guided clinical care in older adultsA review published in the New England Journal of Medicine underscores the critical importance of addressing frailty among older adults.
Read more »
A camu-camu fruit extract to reduce liver fat shows promise in clinical trialA research team from Université Laval has shown the benefits of camu-camu on non-alcoholic fatty liver disease, which affects over seven million people in Canada. This exotic fruit reduces liver fat levels.
Read more »
Clinical trial in Ireland challenges beliefs about Ozempic and similar new obesity treatmentsA study carried out in St Vincent's University Hospital (SVUH) Dublin challenges the belief that weight-loss medications such as Ozempic, Wegovy or Monjaro work just by promoting satiety and making you eat less.
Read more »
New dual-chamber wireless pacemaker shows reliable performance in clinical trialA dual-chamber wireless pacemaker provides reliable performance over three months, bolstering evidence for this new pacemaker option, according to results from a multi-center, international clinical trial co-led by a Weill Cornell Medicine and NewYork-Presbyterian investigator.
Read more »
Cannabinoid Cannabigerol reduces anxiety and stress in first human clinical trialA lesser-known cannabinoid that is gaining in popularity, Cannabigerol (CBG), effectively reduced anxiety in a clinical trial without the intoxication typically associated with whole plant cannabis. It may even have some memory enhancing effects, according to a new study in Scientific Reports.
Read more »
Why clinical trials stop: Researchers find a link between genetic evidence and trial outcomeFailure is the most likely outcome of a clinical trial. Learning from these failures by understanding which factors maximize the chances of a successful trial would help improve the drug discovery process.
Read more »